These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28843433)

  • 1. HDAC inhibitors: A new promising drug class in anti-aging research.
    Pasyukova EG; Vaiserman AM
    Mech Ageing Dev; 2017 Sep; 166():6-15. PubMed ID: 28843433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs.
    McIntyre RL; Daniels EG; Molenaars M; Houtkooper RH; Janssens GE
    EMBO Mol Med; 2019 Sep; 11(9):e9854. PubMed ID: 31368626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epigenetic mechanisms and alcohol use disorders: a potential therapeutic target].
    Legastelois R; Jeanblanc J; Vilpoux C; Bourguet E; Naassila M
    Biol Aujourdhui; 2017; 211(1):83-91. PubMed ID: 28682229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the correct HDAC(s) to treat cognitive disorders.
    Fischer A; Sananbenesi F; Mungenast A; Tsai LH
    Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors: Future therapeutics for insulin resistance and type 2 diabetes.
    Sharma S; Taliyan R
    Pharmacol Res; 2016 Nov; 113(Pt A):320-326. PubMed ID: 27620069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Deacetylase Inhibitors as Anticancer Drugs.
    Eckschlager T; Plch J; Stiborova M; Hrabeta J
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone Deacetylase Inhibitors: An Attractive Therapeutic Strategy Against Breast Cancer.
    Damaskos C; Garmpis N; Valsami S; Kontos M; Spartalis E; Kalampokas T; Kalampokas E; Athanasiou A; Moris D; Daskalopoulou A; Davakis S; Tsourouflis G; Kontzoglou K; Perrea D; Nikiteas N; Dimitroulis D
    Anticancer Res; 2017 Jan; 37(1):35-46. PubMed ID: 28011471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Mekala JR; Naushad SM; Ponnusamy L; Arivazhagan G; Sakthiprasad V; Pal-Bhadra M
    Gene; 2018 Jan; 641():248-258. PubMed ID: 29038000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of the histone deacetylase inhibitor sodium butyrate on the viability and life span in Drosophila melanogaster].
    Vaĭserman AM; Koliada AK; Koshel' NM; Simonenko AV; Pasiukova EG
    Adv Gerontol; 2012; 25(1):126-31. PubMed ID: 22708457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HDAC modulation and cell death in the clinic.
    Dell'Aversana C; Lepore I; Altucci L
    Exp Cell Res; 2012 Jul; 318(11):1229-44. PubMed ID: 22336671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation.
    Chistiakov DA; Orekhov AN; Bobryshev YV
    Int J Cardiol; 2017 Jan; 227():66-82. PubMed ID: 27852009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of HDAC inhibitors in cancer therapy: insights into oral squamous cell carcinoma.
    Iglesias-Linares A; Yañez-Vico RM; González-Moles MA
    Oral Oncol; 2010 May; 46(5):323-9. PubMed ID: 20207580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors and epigenetic regulation in lymphoid malignancies.
    Markozashvili D; Ribrag V; Vassetzky YS
    Invest New Drugs; 2015 Dec; 33(6):1280-91. PubMed ID: 26423245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human neuronal cells: epigenetic aspects.
    Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
    Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting chromatin aging - The epigenetic impact of longevity-associated interventions.
    Field AE; Adams PD
    Exp Gerontol; 2017 Aug; 94():29-33. PubMed ID: 27986499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-fibrotic effects of valproic acid: role of HDAC inhibition and associated mechanisms.
    Khan S; Ahirwar K; Jena G
    Epigenomics; 2016 Aug; 8(8):1087-101. PubMed ID: 27411759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic enzymes: A role in aging and prospects for pharmacological targeting.
    Pasyukova EG; Symonenko AV; Rybina OY; Vaiserman AM
    Ageing Res Rev; 2021 May; 67():101312. PubMed ID: 33657446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [EPIGENETIC ENZYMES AS THERAPEUTIC TARGETS FOR TREATING BRAIN DISORDERS].
    Gomazkov OA
    Eksp Klin Farmakol; 2015; 78(11):35-44. PubMed ID: 27017704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic therapy of cancer with histone deacetylase inhibitors.
    Lakshmaiah KC; Jacob LA; Aparna S; Lokanatha D; Saldanha SC
    J Cancer Res Ther; 2014; 10(3):469-78. PubMed ID: 25313724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic mechanisms underlying lifespan and age-related effects of dietary restriction and the ketogenic diet.
    Moreno CL; Mobbs CV
    Mol Cell Endocrinol; 2017 Nov; 455():33-40. PubMed ID: 27884781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.